{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T12:19:10Z","timestamp":1790079550511,"version":"4.0.1"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T00:00:00Z","timestamp":1766361600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T00:00:00Z","timestamp":1766966400000},"content-version":"vor","delay-in-days":7,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000071","name":"National Institute of Child Health and Human Development","doi-asserted-by":"publisher","award":["R01HD107003"],"award-info":[{"award-number":["R01HD107003"]}],"id":[{"id":"10.13039\/100000071","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Trials"],"DOI":"10.1186\/s13063-025-09374-9","type":"journal-article","created":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T05:47:02Z","timestamp":1766382422000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Darbepoetin plus slow-release IntraVenous Iron to decrease transfusions and improve iron status and neurodevelopment in preterm infants (DIVI): study protocol for a randomized, blinded phase II trial"],"prefix":"10.1186","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6861-6229","authenticated-orcid":false,"given":"Sandra E.","family":"Juul","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bryan A.","family":"Comstock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dennis E.","family":"Mayock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kendell","family":"German","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Feltner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jill","family":"Irvine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eliza","family":"Lagerquist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick J.","family":"Heagerty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,22]]},"reference":[{"issue":"3","key":"9374_CR1","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1056\/NEJMoa1907423","volume":"382","author":"SE Juul","year":"2020","unstructured":"Juul SE, et al. A randomized trial of erythropoietin for neuroprotection in preterm infants. N Engl J Med. 2020;382(3):233\u201343.","journal-title":"N Engl J Med"},{"key":"9374_CR2","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.jpeds.2017.10.041","volume":"194","author":"K German","year":"2018","unstructured":"German K, et al. Zinc protoporphyrin-to-heme ratio and ferritin as measures of iron sufficiency in the neonatal intensive care unit. J Pediatr. 2018;194:47\u201353.","journal-title":"J Pediatr"},{"key":"9374_CR3","doi-asserted-by":"crossref","unstructured":"Valieva OA, et al.\u00a0Effects of transfusions in extremely low birth weight infants: a retrospective study. J Pediatr. 2009;155(3):331\u201337 e1.","DOI":"10.1016\/j.jpeds.2009.02.026"},{"key":"9374_CR4","doi-asserted-by":"crossref","unstructured":"Wu LL, Zhang L, Shao J, Qin YF, Yang RW, Zhao ZY.\u00a0Effect of perinatal iron deficiency on myelination and associated behaviors in rat pups. Behav Brain Res. 2008;188(2):263\u2013270.","DOI":"10.1016\/j.bbr.2007.11.003"},{"key":"9374_CR5","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1159\/000075667","volume":"25","author":"LAJJDWMK Georgieff","year":"2003","unstructured":"Georgieff LAJJDWMK. Perinatal iron deficiency alters apical dendritic growth in hippocampal CA1 pyramidal neurons. Dev Neurosci. 2003;25:412\u201320.","journal-title":"Dev Neurosci"},{"key":"9374_CR6","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1002\/hipo.22151","volume":"23","author":"MT Pisansky","year":"2013","unstructured":"Pisansky MT, et al. Iron deficiency with or without anemia impairs prepulse inhibition of the startle reflex. Hippocampus. 2013;23:952\u201362.","journal-title":"Hippocampus"},{"issue":"1","key":"9374_CR7","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.jpeds.2005.08.052","volume":"148","author":"SM Miller","year":"2006","unstructured":"Miller SM, McPherson RJ, Juul SE. Iron sulfate supplementation decreases zinc protoporphyrin to heme ratio in premature infants. J Pediatr. 2006;148(1):44\u20138.","journal-title":"J Pediatr"},{"key":"9374_CR8","doi-asserted-by":"crossref","unstructured":"Cheng CF, et al.\u00a0Zinc protoporphyrin-to-heme ratios in high-risk and preterm infants. J Pediatr. 2012;161(1):81\u20137 e1.","DOI":"10.1016\/j.jpeds.2011.12.048"},{"issue":"1\u20132","key":"9374_CR9","first-page":"35","volume":"9","author":"B Lonnerdal","year":"1985","unstructured":"Lonnerdal B. Dietary factors affecting trace element bioavailability from human milk, cow\u2019s milk and infant formulas. Prog Food Nutr Sci. 1985;9(1\u20132):35\u201362.","journal-title":"Prog Food Nutr Sci"},{"issue":"3","key":"9374_CR10","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1152\/physrev.1997.77.3.643","volume":"77","author":"B Lonnerdal","year":"1997","unstructured":"Lonnerdal B. Effects of milk and milk components on calcium, magnesium, and trace element absorption during infancy. Physiol Rev. 1997;77(3):643\u201369.","journal-title":"Physiol Rev"},{"issue":"5","key":"9374_CR11","doi-asserted-by":"publisher","first-page":"e132","DOI":"10.1097\/MPG.0000000000003033","volume":"72","author":"T Ho","year":"2021","unstructured":"Ho T, et al. Intestinal microbiome in preterm infants influenced by enteral iron dosing. J Pediatr Gastroenterol Nutr. 2021;72(5):e132-8.","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"1","key":"9374_CR12","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1038\/s41390-020-01273-w","volume":"90","author":"PT Vu","year":"2021","unstructured":"Vu PT, et al. Transfusions and neurodevelopmental outcomes in extremely low gestation neonates enrolled in the PENUT trial: a randomized clinical trial. Pediatr Res. 2021;90(1):109\u201316.","journal-title":"Pediatr Res"},{"key":"9374_CR13","doi-asserted-by":"crossref","unstructured":"German KR, et al.\u00a0Enteral iron supplementation in extremely preterm infants and its positive correlation with neurodevelopment; post hoc analysis of the PENUT randomized controlled trial. J Pediatr. 2021;238:102\u2013109.e8.","DOI":"10.1016\/j.jpeds.2021.07.019"},{"key":"9374_CR14","doi-asserted-by":"publisher","first-page":"S83","DOI":"10.1111\/hdi.12560","volume":"21","author":"M Auerbach","year":"2017","unstructured":"Auerbach M, Macdougall I. The available intravenous iron formulations: history, efficacy, and toxicology. Hemodial Int. 2017;21:S83-92.","journal-title":"Hemodial Int"},{"issue":"3","key":"9374_CR15","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1016\/j.clp.2015.04.016","volume":"42","author":"S Patel","year":"2015","unstructured":"Patel S, Ohls RK. Darbepoetin administration in term and preterm neonates. Clin Perinatol. 2015;42(3):557\u201366.","journal-title":"Clin Perinatol"},{"issue":"1","key":"9374_CR16","doi-asserted-by":"publisher","first-page":"e119","DOI":"10.1542\/peds.2013-0143","volume":"132","author":"RK Ohls","year":"2013","unstructured":"Ohls RK, et al. A randomized, masked, placebo-controlled study of darbepoetin alfa in preterm infants. Pediatrics. 2013;132(1):e119\u201327.","journal-title":"Pediatrics"},{"issue":"11","key":"9374_CR17","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1038\/sj.jp.7211387","volume":"25","author":"TL Warwood","year":"2005","unstructured":"Warwood TL, et al. Single-dose darbepoetin administration to anemic preterm neonates. J Perinatol. 2005;25(11):725\u201330.","journal-title":"J Perinatol"},{"issue":"7","key":"9374_CR18","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.29024","volume":"68","author":"AA Boucher","year":"2021","unstructured":"Boucher AA, et al. A retrospective study of the safety and efficacy of low molecular weight iron dextran for children with iron deficiency anemia. Pediatr Blood Cancer. 2021;68(7):e29024.","journal-title":"Pediatr Blood Cancer"},{"issue":"7","key":"9374_CR19","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1177\/1060028017699429","volume":"51","author":"N Hassan","year":"2017","unstructured":"Hassan N, et al. Intravenous ferumoxytol in pediatric patients with iron deficiency anemia. Ann Pharmacother. 2017;51(7):548\u201354.","journal-title":"Ann Pharmacother"},{"issue":"8","key":"9374_CR20","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.1681\/ASN.2007101156","volume":"19","author":"BS Spinowitz","year":"2008","unstructured":"Spinowitz BS, et al. Ferumoxytol for treating iron deficiency anemia in CKD. J Am Soc Nephrol. 2008;19(8):1599\u2013605.","journal-title":"J Am Soc Nephrol"},{"key":"9374_CR21","doi-asserted-by":"crossref","unstructured":"Provenzano R, Schiller B, Rao M, Coyne D, Brenner L, Pereira BJ. Ferumoxytol as an intravenous iron replacement therapy in hemodialysis patients. Clinical Journal of the American Society of Nephrology: CJASN. 2009;4(2):386\u201393.","DOI":"10.2215\/CJN.02840608"},{"issue":"17","key":"9374_CR22","doi-asserted-by":"publisher","first-page":"5695","DOI":"10.1158\/1078-0432.CCR-10-3420","volume":"17","author":"HE Daldrup-Link","year":"2011","unstructured":"Daldrup-Link HE, et al. MRI of tumor-associated macrophages with clinically applicable iron oxide nanoparticles. Clin Cancer Res. 2011;17(17):5695\u2013704.","journal-title":"Clin Cancer Res"},{"key":"9374_CR23","doi-asserted-by":"crossref","unstructured":"McConnell HL, Schwartz DL, Richardson BE, Woltjer RL, Muldoon LL, Neuwelt EA.\u00a0Ferumoxytol nanoparticle uptake in brain during acute neuroinflammation is cell-specific. Nanomed. 2016;12(6):1535\u201342.","DOI":"10.1016\/j.nano.2016.03.009"},{"key":"9374_CR24","doi-asserted-by":"crossref","unstructured":"Balakrishnan VS, Rao M, Kausz AT, Brenner L, Pereira BJ, Frigo TB, Lewis JM.\u00a0Physicochemical properties of ferumoxytol, a new intravenous iron preparation. Europ J Clin Invest. 2009;39(6):489\u201396.","DOI":"10.1111\/j.1365-2362.2009.02130.x"},{"issue":"3","key":"9374_CR25","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1016\/j.ejpb.2011.03.016","volume":"78","author":"MR Jahn","year":"2011","unstructured":"Jahn MR, et al. A comparative study of the physicochemical properties of iron isomaltoside 1000 (Monofer), a new intravenous iron preparation and its clinical implications. Eur J Pharm Biopharm. 2011;78(3):480\u201391.","journal-title":"Eur J Pharm Biopharm"},{"issue":"10","key":"9374_CR26","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1002\/ajh.22153","volume":"86","author":"M Auerbach","year":"2011","unstructured":"Auerbach M, et al. Safety and efficacy of rapidly administered (one hour) one gram of low molecular weight iron dextran (INFeD) for the treatment of iron deficient anemia. Am J Hematol. 2011;86(10):860\u20132.","journal-title":"Am J Hematol"},{"issue":"6","key":"9374_CR27","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1002\/ajh.24361","volume":"91","author":"L Wong","year":"2016","unstructured":"Wong L, et al. Safety and efficacy of rapid (1,000 mg in 1 hr) intravenous iron dextran for treatment of maternal iron deficient anemia of pregnancy. Am J Hematol. 2016;91(6):590\u20133.","journal-title":"Am J Hematol"},{"issue":"11","key":"9374_CR28","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.1002\/pbc.24676","volume":"60","author":"ES Plummer","year":"2013","unstructured":"Plummer ES, et al. Intravenous low molecular weight iron dextran in children with iron deficiency anemia unresponsive to oral iron. Pediatr Blood Cancer. 2013;60(11):1747\u201352.","journal-title":"Pediatr Blood Cancer"},{"issue":"12","key":"9374_CR29","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.1002\/ajh.25995","volume":"95","author":"J Cohen","year":"2020","unstructured":"Cohen J, et al. A multicenter study evaluating the effectiveness and safety of single-dose low molecular weight iron dextran vs single-dose ferumoxytol for the treatment of iron deficiency. Am J Hematol. 2020;95(12):1572\u20137.","journal-title":"Am J Hematol"},{"key":"9374_CR30","doi-asserted-by":"crossref","unstructured":"Siimes MA, Addiego Jr JE, Dallman PR.\u00a0Ferritin in serum: diagnosis of iron deficiency and iron overload in infants and children. Blood. 1974;43(4):581\u2013590.","DOI":"10.1182\/blood.V43.4.581.581"},{"key":"9374_CR31","doi-asserted-by":"crossref","unstructured":"Siddappa AM, Rao R, Long JD, Widness JA, Georgieff MK.\u00a0The assessment of newborn iron stores at birth: a review of the literature and standards for ferritin concentrations. Neonatol. 2007;92(2):73\u201382.","DOI":"10.1159\/000100805"},{"key":"9374_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2019\/1279250","volume":"2019","author":"M Katerji","year":"2019","unstructured":"Katerji M, Filippova M, Duerksen-Hughes P. Approaches and methods to measure oxidative stress in clinical samples: research applications in the cancer field. Oxid Med Cell Longev. 2019;2019:1\u201329.","journal-title":"Oxid Med Cell Longev"},{"issue":"2","key":"9374_CR33","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","volume":"42","author":"PA Harris","year":"2009","unstructured":"Harris PA, et al. Research electronic data capture (REDCap) - a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009;42(2):377\u201381.","journal-title":"J Biomed Inform"},{"issue":"1","key":"9374_CR34","doi-asserted-by":"publisher","first-page":"F11","DOI":"10.1136\/adc.2003.048488","volume":"90","author":"JS Dorling","year":"2005","unstructured":"Dorling JS. Neonatal disease severity scoring systems. Arch Dis Child Fetal Neonatal Ed. 2005;90(1):F11\u20136.","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"issue":"1","key":"9374_CR35","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1093\/biomet\/73.1.13","volume":"73","author":"KY Liang","year":"1986","unstructured":"Liang KY, Zeger SL. Longitudinal data analysis using generalized linear models. Biometrika. 1986;73(1):13\u201322.","journal-title":"Biometrika"},{"key":"9374_CR36","doi-asserted-by":"publisher","DOI":"10.1002\/9780470510445","volume-title":"Missing data in clinical studies","author":"G Molenberghs","year":"2007","unstructured":"Molenberghs G, Kenward MG. Missing data in clinical studies. Wiley; 2007."},{"key":"9374_CR37","doi-asserted-by":"crossref","unstructured":"Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals. International Committee of Medical Journal Editors. 2025.","DOI":"10.12771\/emj.2024.e48"}],"container-title":["Trials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13063-025-09374-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-025-09374-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-025-09374-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T21:00:22Z","timestamp":1767042022000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13063-025-09374-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,22]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["9374"],"URL":"https:\/\/doi.org\/10.1186\/s13063-025-09374-9","relation":{},"ISSN":["1745-6215"],"issn-type":[{"value":"1745-6215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,22]]},"assertion":[{"value":"25 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"UW Ethical Review Board version 1.5 for STUDY00015143 has been approved. Written, informed consent to participate is obtained from all participants.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate {30}"}},{"value":"A model consent form is available in Supplement 1.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests {7b}"}}],"article-number":"590"}}